Cargando…

Prognostic impact of PTK6 expression in triple negative breast cancer

BACKGROUND: The aim of this study was to investigate the expression of PTK6 in different groups of triple negative breast cancer and its impact on prognosis. METHODS: Retrospective study of a total of 209 surgical specimens of breast cancer were identified by IHC or FISH methods as triple negative,a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yuexia, Qu, Wei, Tu, Jianhong, Yang, Liu, Gui, Xingxing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629122/ https://www.ncbi.nlm.nih.gov/pubmed/37932734 http://dx.doi.org/10.1186/s12905-023-02736-y

Ejemplares similares

Comprehensive Analysis Reveals PTK6 as a Prognostic Biomarker Involved in the Immunosuppressive Microenvironment in Breast Cancer
por: Wang, Lili, et al.
Publicado: (2022)

PTK-7 Expression in Gastric Cancer: A Prognostic Determinant
por: Özçelik, Melike, et al.
Publicado: (2020)

Prognostic value of protein tyrosine kinase 6 (PTK6) for long-term survival of breast cancer patients
por: Aubele, M, et al.
Publicado: (2008)

Expression of protein tyrosine kinase 6 (PTK6) in nonsmall cell lung cancer and their clinical and prognostic significance
por: Zhao, Chao, et al.
Publicado: (2013)

PTEN is a protein phosphatase that targets active PTK6 and inhibits PTK6 oncogenic signaling in prostate cancer
por: Wozniak, Darren J., et al.
Publicado: (2017)

Identification of PTK2 as an adverse prognostic biomarker in breast cancer by integrated bioinformatics and experimental analyses
por: Chen, Yanru, et al.
Publicado: (2022)

PTK6/BRK is expressed in the normal mammary gland and activated at the plasma membrane in breast tumors
por: Peng, Maoyu, et al.
Publicado: (2014)

Expression and Prognostic Significance of BANF1 in Triple-Negative Breast Cancer
por: Zhang, Genhao
Publicado: (2020)

Prognostic Significance of CCNB2 Expression in Triple-Negative Breast Cancer
por: Cao, Jintao, et al.
Publicado: (2021)

Small molecule inhibitors reveal PTK6 kinase is not an oncogenic driver in breast cancers
por: Qiu, Luping, et al.
Publicado: (2018)

Brk/PTK6 and Involucrin Expression May Predict Breast Cancer Cell Responses to Vitamin D3
por: Box, Carol, et al.
Publicado: (2023)

PTK 7 Is a Transforming Gene and Prognostic Marker for Breast Cancer and Nodal Metastasis Involvement
por: Gärtner, Silvia, et al.
Publicado: (2014)

SAT-133 Breast Tumor Kinase (Brk/PTK6) Mediates Triple Negative Breast Cancer Cell Migration and Taxol Resistance via SH2 Domain-Dependent Activation of RhoA and AhR
por: Dwyer, Amy Renee, et al.
Publicado: (2020)

Expression pattern and prognostic impact of glycoprotein non-metastatic B (GPNMB) in triple-negative breast cancer
por: Huang, Yu-Hsiang, et al.
Publicado: (2021)

PTK6 regulates growth and survival of endocrine therapy-resistant ER+ breast cancer cells
por: Ito, Koichi, et al.
Publicado: (2017)

Prognostic value of ERBB4 expression in patients with triple negative breast cancer
por: Kim, Ji-Yeon, et al.
Publicado: (2016)

Prognostic value of IMP3 immunohistochemical expression in triple negative breast cancer
por: Sjekloča, Nikoleta, et al.
Publicado: (2020)

Triple negative breast cancer – prognostic factors and survival
por: Ovcaricek, Tanja, et al.
Publicado: (2010)

Prognostic values of EDNRB in triple-negative breast cancer
por: Liu, Shaoqing, et al.
Publicado: (2020)

Mouse mammary stem cells express prognostic markers for triple-negative breast cancer
por: Soady, Kelly J, et al.
Publicado: (2015)

Development of an immune-related prognostic biomarker for triple-negative breast cancer
por: Zhang, Yan, et al.
Publicado: (2022)

Prognostic impact of AnxA1 and AnxA2 gene expression in triple-negative breast cancer
por: Gibbs, Lee D., et al.
Publicado: (2017)

Impact of central obesity on prognostic outcome of triple negative breast cancer in Chinese women
por: Chen, Hong-liang, et al.
Publicado: (2016)

Prognostic impact of a tumor-infiltrating lymphocyte subtype in triple negative cancer of the breast
por: Jamiyan, Tsengelmaa, et al.
Publicado: (2020)

Overexpression of PTK6 predicts poor prognosis in bladder cancer patients
por: Xu, Xue-lian, et al.
Publicado: (2017)

Anti-PTK7 Monoclonal Antibodies Inhibit Angiogenesis by Suppressing PTK7 Function
por: Oh, Si Won, et al.
Publicado: (2022)

Breast tumor kinase (Brk/PTK6) plays a role in the differentiation of primary keratinocytes
por: Tupper, J., et al.
Publicado: (2011)

High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer
por: Zagouri, F, et al.
Publicado: (2013)

Lack of prognostic significance of adiponectin immunohistochemical expression in patients with triple-negative breast cancer
por: Cubukcu, Erdem, et al.
Publicado: (2014)

Expression of ARs in triple negative breast cancer tumors: a potential prognostic factor?
por: Giannos, Aris, et al.
Publicado: (2015)

Prognostic significance of adipophilin expression in biopsy specimens of patients with triple-negative breast cancer
por: Yoshikawa, Katsuhiro, et al.
Publicado: (2022)

The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer
por: Rhee, Jiyoung, et al.
Publicado: (2008)

Endocan as a prognostic biomarker of triple-negative breast cancer
por: Sagara, Atsunobu, et al.
Publicado: (2016)

Exploring specific prognostic biomarkers in triple-negative breast cancer
por: Bao, Chang, et al.
Publicado: (2019)

PTK2 and PTPN11 expression in myelodysplastic syndromes
por: Lazarini, Mariana, et al.
Publicado: (2013)

Prognostic and predictive value of Ki-67 in triple-negative breast cancer
por: Wang, Wei, et al.
Publicado: (2016)

Kinetochore microtubules in PTK cells
Publicado: (1992)

Prognostic significance of GSTP1 in patients with triple negative breast cancer
por: Chen, Guanglei, et al.
Publicado: (2017)

Repeated phototherapeutic keratectomy (PTK) followed by PTK with photorefractive keratectomy for anterior granular corneal dystrophy
por: Sridhar, Uma, et al.
Publicado: (2020)

The association of CMTM6 expression with prognosis and PD-L1 expression in triple-negative breast cancer
por: Tian, Yiping, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n033jkhm5gpab6s20279cd3l9h